Cancer Genetics Program
The Cancer Genetics Program is a joint service between the Division of Hematology/Oncology and the Division of Clinical Genetics. The goal of our program is to prevent cancer, or if cancer occurs, to detect it as early as possible by identifying individuals at increased risk.
We provide individualized cancer risk assessment and health management recommendations to individuals and families at increased risk for cancer due to their personal and/or family history of cancer.
The Cancer Genetics Program is under the direction of Lee Shulman, MD (Geneticist, Division of Clinical Genetics) and Virginia Kaklamani, MD (Medical Oncologist, Division of Hematology/ Oncology) and a multidisciplinary team comprised of genetic counselors, medical oncologists and medical geneticists.
To schedule an appointment for your personalized risk assessment, contact the Cancer Genetics Program at 312-695-0320.
News & Events
Date: December 1, 2010
Lee P. Shulman, Co-director of the Cancer Genetics Program, receives International recognition as a Visiting Professor at Queen Elizabeth Hospital, Hong Kong University and as an Invited Moderator and Speaker at the Asia-Pacific Society of Human Genetics in Hong Kong.
Interview - Breast Cancer Awareness Improving
Date: October 6, 2010
Dr Virginia Kaklamani, Co-director of the Cancer Genetics Program, recently spoke with Fox News Chicago about breast cancer prevention and new treatments. Read More
Award - Best Clinical Obstetrics Poster
Date: October 1, 2010
Lee P Shulman receives “Best Clinical Obstetrics Poster” for a poster presented at the Central Association of Obstetricians and Gynecologists, 77th Annual Meeting, Las Vegas, NV, 2010
Citation: Ginsberg NA, Dungan JS, Cohen L, Shulman LP. Absence of the fourth ventricle in first-trimester fetuses: the Intracranial Translucency (IT) as a potential screening tool for fetal neural tube defects in the late first trimester.
Award - Best Gynecologic Clinical Poster
Date: October 1, 2010
Lee P Shulman receives “Best Gynecologic Clinical Poster” for a poster presented at the Central Association of Obstetricians and Gynecologists, 77th Annual Meeting, Las Vegas, NV, 2010
Citation: Stewart CJ, Dungan JS, Singh DK, Collins C, Shulman LP. Unaffected women with BRCA 1/2 mutations and their use of family history in making decisions concerning prophylactic surgery.
Editorial - Lessons Learned from Genetic Testing
Date: September 1, 2010
Dr Virginia Kaklamani and colleague Dr Laura Esserman wrote an editorial about a recently published article by Domchek et al. comparing risk-reducing surgeries in BRCA1/2 mutation carriers with cancer risk and mortality. Read More
Physicians in the Practice
Genetic Counselors in the Practice
Monday through Friday
8 a.m. to 5 p.m.
676 N. St. Clair
Chicago, Illinois 60611
Practice Number: 312-695-0320